Sign Up to Receive Your Personalised Learning Resources
CONFERENCE HUB
Per Ljungman, EBMT23: Outcomes and mortality in cytomegalovirus seropositive allogeneic stem cell transplantation patients with COVID-19
Start Learning
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Anna Sureda, EBMT23: Updates on the GoCART coalition
View
Marina Kremyanskaya, EHA 2023: Findings of the REVIVE study of rusfertide in polycythaemia vera
View
Phase III APPLY-PNH and APPOINT-PNH trials investigate iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria, 48-week data: Phillip Scheinberg, ASH 2023
View
Phase 3 BASIS trial – efficacy and safety of marstacimab in severe haemophilia A or B without inhibitors: Davide Matino, ASH 2023
View
IMerge Phase 3 study – Imetelstat achieving RBC-TI in lower-risk myelodysplastic syndromes: Rami Komrokji, ASH 2023
View
Revumenib in relapsed/refractory KMT2Ar acute leukaemia – AUGMENT-101 phase 2 study: Ibrahim Aldoss, ASH 2023
View
The evolving treatment landscape in relapsed/refractory multiple myeloma
View
Key considerations for treatment selection and sequencing in patients with RRMM: Lessons from real-life clinical practice
View
Managing the practicalities of CAR T-cell therapies in patients with R/R MCL: Current considerations and future strategies
View
John Mascarenhas, EHA 2023: Phase II MANIFEST trial: Pelabresib combined with ruxolitinib for patients with myelofibrosis
View